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Most recent estimates indicate that 1 in 68 children are affected by an autism spectrum
disorder (ASD). Though decades of research have uncovered much about these disorders,
the pathological mechanism remains unknown. Hampering efforts is the seeming
inability to integrate findings over the micro to macro scales of study, from changes in
molecular, synaptic and cellular function to large-scale brain dysfunction impacting sensory,
communicative, motor and cognitive activity. In this review, we describe how studies
focusing on neuronal circuit function provide unique context for identifying common
neurobiological disease mechanisms of ASD. We discuss how recent EEG and MEG
studies in subjects with ASD have repeatedly shown alterations in ensemble population
recordings (both in simple evoked related potential latencies and specific frequency
subcomponents). Because these disease-associated electrophysiological abnormalities
have been recapitulated in rodent models, studying circuit differences in these models
may provide access to abnormal circuit function found in ASD. We then identify
emerging in vivo and ex vivo techniques, focusing on how these assays can characterize
circuit level dysfunction and determine if these abnormalities underlie abnormal clinical
electrophysiology. Such circuit level study in animal models may help us understand how
diverse genetic and environmental risks can produce a common set of EEG, MEG and
anatomical abnormalities found in ASD.
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THE PROMISE OF TRANSLATIONAL PHENOTYPES IN ASD
Autism spectrum disorders (ASD) have an estimated prevalence
of 1 in 68 children, potentially reaching as high as 1 in 42 males
(Developmental Disabilities Monitoring Network Surveillance
Year 2010 Principal Investigators; Centers for Disease Control
and Prevention (CDC), 2014). Although the criterion for ASD
has recently been updated, it is still considered a disorder of
social impairments and restricted/repetitive behaviors (American
Psychiatric Association, 2013). Findings of multiple weak or rare
and often non-specific genetic or environmental etiologies of
ASD have made it difficult to identify the common neurobio-
logical mechanisms underlying behavioral features that define
ASD. Despite this genetic and phenotypic heterogeneity, research
over the last decade using Electroencephalography (EEG) and
Magnetoencephalography (MEG) (E/MEG) has identified con-
sistent differences in ASD electrophysiology, indicating common
neural circuit disruptions (Wilson et al., 2007; Roberts et al.,
2008; Gandal et al., 2010; Rojas et al., 2011; Edgar et al., 2013).
Unfortunately the neuronal underpinnings of these electrophys-
iological biomarkers of ASD are not understood. The goal of
this review is to describe emerging approaches in animal models
to identify the circuit mechanisms that underlie these clinical
E/MEG findings. To do so we first summarize the current lit-
erature of observed alterations to neural circuits in ASD, with
a focus on mechanisms that may underlie the E/MEG pheno-
types found in human subjects. Second, we propose that it is
at the mesoscopic circuit level, particularly local circuit func-
tion that leads to high frequency activity, where many diverse
alterations must integrate to produce the symptomatology of
ASD. Finally, we highlight emerging techniques in assaying neural
circuit abnormalities that may identify the clinical differences
found in high frequency cortical activity. Thus we hope to iden-
tify how the basic science of oscillatory activity and connec-
tivity in the brain, combined with known E/MEG phenotypes
of ASD, can provide the basis for new testable hypotheses of
ASD.
THE CHALLENGE OF INTEGRATING MULTIPLE PATHOGENIC
MECHANISMS: NO SMOKING GUN
Studies over the last 40 years have revealed a multitude of alter-
ations in ASD, ranging from genetic risk factors, to differences
in whole brain connectivity (Pardo and Eberhart, 2007). As
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genetic screening began to investigate the inheritance profile of
ASD, it was hypothesized that ASD may be operating on the
polygenetic interaction of three genes, and that this interaction
could be revealed in a sample of 60 pairs of ASD affected siblings
(Piven, 1997). Within 8 years this estimate of underlying genetic
profile of ASD had increased to involve 15 genes, along with
strong indication of environmental factors (e.g., prenatal insults)
(Santangelo and Tsatsanis, 2005). This trajectory of etiological
complexity continues. Despite the presence of a disorder that
impacts well over 1 in a 100 individuals, there is not a single
gene or set of genes that strongly or exclusively generate ASD,
and we have been unable to extrapolate any individual puta-
tive genetic deficits to neurological abnormalities that produce
symptoms of ASD. Nevertheless, to produce the constellation
of symptoms that define ASD, different genetic and other alter-
ations involved in the production of ASD likely act further
downstream to converge on common effectors that produces
the symptomatology of ASD. Finding such a common factor
at the neuronal level for ASD or related endophenotypes is a
clear goal in the field of ASD research, yet success has been
limited.
MULTIPLE SYNAPTIC RECEPTORS AND NEUROTRANSMITTERS ARE
AFFECTED IN ASD, WITH NO SINGLE COHERENT EFFECT
Given this significant genetic heterogeneity, recent work has
focused on identifying common networks and molecular path-
ways that may integrate multiple diverse disease risk factors
(Parikshak et al., 2013). For example, a large number of ASD
candidate genes are involved in developing, maintaining, or
modulating synaptic connectivity. A genetic alteration repeat-
edly found in ASD is the duplication of the 15q11–13 locus,
which is estimated to be presented in as high as 3% of the
idiopathic ASD population (Meguro-Horike et al., 2011). This
region is known to contain many genes that encode for GABA
related proteins, such as postsynaptic GABA receptors. Sep-
arately, others have found that both GABAA (Fatemi et al.,
2009b) and GABAB (Fatemi et al., 2009a) receptors levels are
significantly decreased in postmortem brain samples from sub-
jects with ASD. On the synthesis side of GABA signaling,
GAD65 and 67 expression is decreased around 50% (Fatemi
et al., 2002). Recent brain imaging studies have corroborated
GABAergic post-mortem results, demonstrating decreased cor-
tical GABA levels (Harada et al., 2011; Rojas et al., 2014),
with some regional heterogeneity across the cortex (Gaetz et al.,
2014).
γ -Aminobutyric acid signaling is not the only neurotransmit-
ter system affected in ASD; glutamatergic signaling is also affected,
with the expression of multiple genes and proteins regulating this
signaling pathway (e.g., EAAT and AMPA isotypes) increased in
cerebellar cortex of subjects with autism (Purcell et al., 2001).
This finding of increased glutamatergic expression fits with recent
in vivo findings using magnetic resonance spectroscopy (Brown
et al., 2013), although the exact meaning of these results are
unclear. Lastly the GluR6, a kainate receptor subunit, has been
strongly linked to ASD risk (Jamain et al., 2002; Shuang et al.,
2004; Strutz-Seebohm et al., 2006). This, when combined with
glutamatergic phenotypes in mouse models that recapitulate key
aspects of ASD, has led to hypotheses that altered glutamate
transmission may contribute to the core phenotypes of ASD
(Carlson, 2012).
As glutamate and GABA receptors comprise the majority of
ligand-gated ion channels in the CNS, these genetic findings sup-
port the general neurophysiological hypothesis that a disruption
of excitation/inhibition (E/I) balance contributes to the disorder
(Rubenstein and Merzenich, 2003). Such proposed imbalance
has been a common theme in multiple psychiatric and neuro-
logic disorders, including Alzheimer’s disease, schizophrenia and
epilepsy (Eichler and Meier, 2008). Yet, though there may be
similarities between those disorders and ASD, there are differences
in the development and symptoms of these diseases that must
be explained by specific neurobiological mechanisms to explain
the divergent symptoms. While this idea is limited in specificity;
if E/I imbalance is one of the underlying principle components
of ASD, an immediate consequence such an alteration would be
perturbed circuit activity underlying oscillatory activity in the
brain. Oscillations across the frequency spectrum are evidenced
and theorized to be dependent on the strength and kinetics of
inhibitory and excitatory synaptic interactions at the mesocir-
cuit level (Buzsáki and Wang, 2012). While again, this is not
specific to ASD, other disorders such as schizophrenia (Kwon
et al., 1999) and bipolar disorder (Maharajh et al., 2007) also
show alterations to oscillatory function. What may distinguish
ASD is the exact circuitry involved, the developmental timing
of the disruption or the set of neurophysiological abnormalities
due to specific genetic and environmental factors. For instance,
preclinical work has shown that altered high frequency activity
due to E/I imbalance generated in prefrontal regions but not
visual cortex, is sufficient for the production of social and fear-
related, but not locomotive impairments (Yizhar et al., 2011).
Furthermore, this was limited to specifically CAMKII but not
PV expressing neurons. In humans, oscillatory activity in spe-
cific regions have been shown to scale with impairment mea-
sures of autism specific behaviors or social ability in various
conditions including, response to auditory stimuli (Rojas et al.,
2011), resting (Cornew et al., 2012) or prestimulus (Edgar et al.,
2013). Specificity may come from the overlap of the genetic
risks for multiple psychiatric disorders (Cross-Disorder Group of
the Psychiatric Genomics Consortium; Genetic Risk Outcome of
Psychosis (GROUP) Consortium, 2013). It is proposed that the
genetic risks are not specific to disorders, but rather domains of
symptomatology instead. For instance pre-frontal E/I imbalance,
due to the genetic risks common to ASD and schizophrenia,
may lead to social impairments that are shared between the
disorders.
NEUROMODULATORS AFFECTED IN ASD
Strengthening the concept that there are multiple synaptic paths
to a common circuit dysregulation in ASD, is the evidence that
neuromodulatory systems are also disrupted. Looking through
the lens of E/I imbalance, neuromodulators can act at the synapse
directly or on the firing properties of a cell to alter the strength,
kinetics and firing probability of cells involved in circuit E/I
balance and thus impacting neural functioning in ASD. In fact
some of the earliest examined neurological abnormalities in ASD
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involved neuromodulatory systems (Boullin et al., 1970; Modahl
et al., 1998), several of which are now known to be involved
in emotional and social regulation. Peptide and monoaminergic
transmitters appear aberrant in ASD, in particular the oxytocin
and serotoninergic systems. These neuromodulators are of inter-
est, because of oxytocin’s role in social behavior and bonding
(Lieberwirth and Wang, 2014) partnered with a potential for
treatment efficacy (Gordon et al., 2013; Tyzio et al., 2014), and the
current use of pharmacological agents aimed at the serotoniergic
system for treatment of ASD symptomatology. Both of these
systems can impact cell excitability in an anatomical and cell-
type specific manner. Oxytocin signaling is thought to be reduced
in ASD (Modahl et al., 1998) and has been an intense focus for
therapeutic intervention (Weisman et al., 2012; Gordon et al.,
2013) and recent research at the circuit level (Owen et al., 2013).
Individuals with ASD also exhibit hyperserotonemia, potentially
arising from mutations in SLC6A4 and MAOA candidate genes
(Harrington et al., 2013). The affect of the such genes may be
two fold, serotonin plays an important role in the development
of cortical and sub-cortical tissues, not only as a neurotransmitter
but also earlier during development (Whitaker-Azmitia, 2001).
The serotonin system remains altered in ASD during the juvenile
period with an altered developmental trajectory of serotonin
synthesis (Chugani et al., 1999). Interestingly in adults, if the
levels of the precursor of serotonin is lowered via specific dietary
manipulations, ASD symptomatology is exacerbated, again point-
ing to serotonin’s role in ASD (McDougle et al., 1996). This
role of serotonin has been replicated in animal models, rats
prenatally treated with 5-methoxytryptamine (5-MT), an agonist
of serotonin receptors, demonstrate ASD like symptomatology
and alterations to regions known to be involved in social activity
and peptides release (such as oxytocin) (McNamara et al., 2008).
Acetylcholine (ACH) has also been focus of research with
regards to pathology and treatment in ASD. Multiple studies show
altered ACH related findings, such as decreased Positron emission
tomography (PET) binding, altered post mortem immunoreactiv-
ity for receptors and mRNA, and decreased relative choline levels
in in vivo in ASD (Deutsch et al., 2010). Interestingly, increasing
levels of ACH specifically in striatal regions allows for the recovery
of social and cognitive flexibility in an animal model that is
thought to recapitulate those aspects of ASD (Karvat and Kimchi,
2014).
Another major neuromodulator linked to ASD is dopamine.
Several studies have shown that dopamine is increase in frontal
cortex (Chugani, 2012), and multiple genetic studies have linked
dopamine associated genes with ASD (Nguyen et al., 2014).
Consistent for a role of dopamine signaling in ASD, is their
importance in mediating repetitive and stereotyped behaviors.
Both from human genetic findings (Staal, 2014) and mice models
(Chartoff et al., 2001). While oxytocin continues to be examined
as a potential treatment, current drugs targeting these and other
systems have not been found to be effective in treating core
symptoms of ASD (Warren et al., 2011), suggesting that these
modulatory system contribute to, but do not drive the disorder.
This non-exhaustive summary of alterations to the neu-
rotransmitter and neuro-modulator systems suggests targets
for treatment, yet also indicate that no single target will be
broadly effective. Single perturbations are not consistently present
throughout all cases of ASD, and furthermore such alterations
are usually found in differing combinations; yet ultimately they
synergize to produce the symptomatology known as ASD. Thus,
hypothesis such as E/I balance suggests common neuronal circuit
differences that could be targeted to repair circuit function in
ASD.
IMMUNE SYSTEM DYSFUNCTION
Maternal infections, fever and antibiotic treatment, as well as
post-natal infections, are associated with an increased likelihood
of the child being diagnosed with ASD (Hsiao, 2013). This
relationship can be modeled in animals via injections of various
components of pathogens, which lead to the discovery that the
immune response driven by cytokines that can produce this link
(Garay and McAllister, 2010). Of note, is the evidence from
several studies that autoimmune diseases and/or allergies are at
a greater prevalence in ASD (Hsiao, 2013). In fact it has been
demonstrated that maternal antibodies reactive to fetal tissue are
linked to ASD (Fox et al., 2012). These brain targeting antibodies
also are found in patients with ASD, and certain sub-types corre-
late with specific ASD behavioral symptoms (Goines et al., 2011).
At the cellular level, evidence of immune system involvement is
found in ASD, with increased activation and number of migroglial
cells both in patients with ASD and animal models that recapitu-
late ASD via genetic or environmental insults (Hsiao, 2013). The
major histocompatibility complex (MHC) locus, a region of the
genetic code which contains genes for immune system function-
ing, is of particular note to circuit function in ASD. Multiple genes
and haplotypes in the MHC local are linked to higher incidence
of autism (Needleman and McAllister, 2012). These MHC genes
are important for neuronal development, connectivity, and circuit
function (see Section Cellular Assessment of Circuit Activity:
Targeting the Neurophysiology of Local Circuit Dysfunction in
ASD).
STRUCTURAL AND CONNECTIVITY ALTERATIONS ARE PRESENT IN ASD
Sub-cellular and synaptic alterations are not the only alterations
found in ASD. At the level of local cytoarchitecture, post-mortem
studies of individuals with ASD have shown increases in the
density of minicolumns in multiple cortical regions, while each
column itself is narrower, primarily due to decreases in peripheral
neuropil compartments (Casanova et al., 2010). These cytoarchi-
tectural changes are in concert with increased rates of macro-
cephaly in individuals with ASD, for which increases in brain vol-
ume are disproportionately greater for local cortical white matter
connections (Herbert, 2005). Such local increases in anatomical
connectivity, observed in ASD as an increase in local white matter
tracts, may exist alongside decreases in long-range connectivity
(Jou et al., 2011). Of note, alterations in long range connectivity
have been correlated with electrophysiological deficits in bottom-
up sensory processing (Roberts et al., 2009). Thus, ASD are associ-
ated with alterations across function, modulation, and structure.
While there are likely causal relationships between alteration in
any of these components (activity during development leading
to structural changes or vice versa), the heterogeneity of any of
these findings within and outside ASD also suggest that they can
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combine to produce a common set of neurological abnormalities.
Assaying the combined and potentially differing impact of these
diverse potential etiologies is limited in human patients and
technically difficult in model systems.
EEG AND MEG STUDIES PRESENT COMMON CLINICAL
NEUROPHYSIOLOGICAL DIFFERENCES IN ASD
In contrast to the divergent assortment of complex combinatorial
risks found for ASD, clinical electrophysiology has identified
specific resting, event related potential, and spectral changes that
suggest common neural circuit function abnormalities (Figure 1).
In particular spectro-temporal processing of auditory stimuli in
ASD demonstrates deficits in gamma-band activity (30–50 Hz)
(Wilson et al., 2007; Rojas et al., 2008; Gandal et al., 2010; Edgar
et al., 2013). These alterations in stimulus-produced responses
occur alongside aberrant resting state profile in ASD (Orekhova
et al., 2007; Cornew et al., 2012). As such, coherent alterations
have been identified in ASD, which point to common neurobi-
ological underpinning. Because of the complexity of the neuro-
physiology underlying these clinical electrophysiological findings,
there are many points where differing etiologies could perturb
these measures. This poses the critical question: How is the
ensemble neuronal activity that generates the EEG and MEG
signals perturbed in ASD?
ASD RELATED E/MEG ENDOPHENOTYPES ARE REPLICATED IN
MULTIPLE MODELS RELATED TO ASD AND POINT TO LOCAL CIRCUIT
CHANGE
The alterations detected via E/MEG in auditory event related
potentials and gamma-band abnormalities have been a focus of
translational research, since auditory processing in mice, rats and
humans is remarkably well conserved (Figure 1). Event related
potentials themselves have shown an increased latency in both
MEG and EEG in ASD and representative animal models respec-
tively. These findings indicate differences in the speed of auditory
processing as information is passed via auditory nuclei to the
cortex (Figures 1A,C). Auditory responses to stimuli can also
be separated into their spectral subcomponents, which exhibit
a strong phase-locked gamma band activity between 30–50 Hz
(Figures 1B,E). This ability of a subject to produce an alignment
of gamma-band phases over multiple trials with respect to the
stimuli can be viewed as the local circuit’s reliability. The less able
the system is to respond to an input with an appropriate and
controlled response, the more dysfunctional the system will be.
This is especially important when the responses are basic sensory
responses that need to be combined into meaningful stimuli.
This quality of phase-locked activity between trials (reflected as
ITC in Figure 1) is decreased in ASD individuals compared to
typically developing age-matched subjects (TD). This finding has
been replicated across research groups (Rojas et al., 2008; Gandal
et al., 2010). Similarly, evoked gamma-band power in response to
analogous auditory stimuli is also decreased in ASD, and animal
models that recapitulate key phenotypes of ASD (Figure 1D;
Gandal et al., 2010, 2012a; Saunders et al., 2012), suggesting
neuronal mechanisms are shared between ASD and these models
of the disorder. While ITC and evoked power are very similar
entities, they remain crucially separate (Box 1).
BOX 1 | ITC vs. evoked power, similar yet not redundant.
Changes seen in ITC and evoked activity are related, since both
are referring to phase and time locked activity, though ITC is
questioning “what fraction of signals are in phase”, and evoked
power asks “of those time and phase locked, what is the amplitude
of the response”. If there are no in-phase signals then ITC would
equal 0, and evoked power would also be 0. If responses were
perfectly in phase ITC would equal 1 (its maximum possible value),
and evoked power would be the amplitude of the resulting wave.
Yet, because ITC is only a measure of trial-to-trial phase reliability
and not the amplitude of power generated by the stimulus, ITC
can be independently disrupted. Such a case could occur when
a manipulation could increase the ability cells to more temporally
accurately fire, but the total amount of cells firing is reduced.
In contrast to the loss of phase reliability across repeated
stimuli, other findings in the gamma band are an increase in
baseline spectral activity in ASD and increased stimulus related
non-phase locked activity (often called “induced” activity (Wilson
et al., 2007; Edgar et al., 2013 respectively)). Increases in gamma
activity related to an event or stimuli that is not phase locked has
traditionally been presumed to be involved in higher cognitive
processing of the signal (Tallon-Baudry and Bertrand, 1999),
but a feature in ASD is that the increase in induced activity
appears coupled to a reduction in evoked activity, suggesting
that in ASD there is a reduction in the ability of the brain to
respond reliably to a event/stimulus and it is this loss phase-locked
activity that may be increasing induced activity (Wilson et al.,
2007).
From the multiple putative neuronal differences indicated
in ASD it should not be surprising that gamma-band activ-
ity is impacted. The generation of high frequency oscillatory
activity during ensemble activity requires low latency feed-
back between inhibitory and excitatory neurons, in the case
of 40 Hz activity one cycle of activity must comprise 25 ms.
Gamma-band activity is also sensitive to behavioral states and
their associated neuromodulators (Schadow et al., 2009; Kim
et al., 2014). Finally, unlike the event related potential latencies,
changes in gamma-frequency may be due primarily to local
changes in circuit connectivity (Kopell et al., 2000; Cardin et al.,
2009; Wang and Carlén, 2012). Because of gamma’s depen-
dence on local circuit function, many mechanisms of gamma
can be assayed in brain slices. Thus, focusing on gamma-band
changes in ASD and rodent models that share EEG valid-
ity with ASD (Gandal et al., 2010, 2012a,c; Saunders et al.,
2012) may provide a path to directly assay mechanisms of
gamma-band dysfunction using the enhanced access of in vitro
preparations.
PROMISE OF CIRCUIT LEVEL FOCUSED EXAMINATION OF ASD:
POTENTIAL FOR TRANSLATION BETWEEN MODEL SYSTEMS AND
INQUIRY AT MULTIPLE SCALES
Mesoscopic level examination of circuits, and in particular micro-
circuits, maybe be the ideal area for investigation, because they
integrate multiple sub-cellular to systems alterations. Not only
is ensemble activity sensitive to genetic (Carlson et al., 2011),
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FIGURE 1 | Intermediate phenotypes seen in human subjects are
translatable to animal models that recapitulate differing aspects of ASD.
(A) Representative dipole/electrode placement (top) and ERP trace (bottom)
for control human (left) and mouse (right) appear qualitatively similar. (B)
Time-frequency plots of phase-locking factor for humans (left panel) and
mouse (right panel) exhibit direct translatability. Note the decrease in phase
locking in gamma frequencies in both ASD and an environmental insult based
model of ASD. (C) Event-related potential latencies are delayed both in
children with ASD and animal models of ASD utilizing prenatal insult, genetic
insult and pharmacological treatment. Similar deficits in gamma-band
responses are seen between children with ASD and numerous animal models
of ASD with varying biological mechanisms for both evoked power (D) and
inter-trial coherence/phase-locking factor (ITC/PLF) (E). (F) The observed
alterations to the spectral response are specific to gamma-band frequencies
when examined in an animal model recapitulating keep aspects of ASD. (G)
As proof of the predictive validity of translational electrophysiology, increases
in baseline activity, first observed in animal models utilizing a genetic basis
(G), have been demonstrated in children with ASD (H). *** P < 0.001,
** P < 0.01, * P < 0.05, # P < 0.1 Figure adapted from Gandal et al.
(2010)—(A–E), Gandal et al. (2012a)—(C–E), Gandal et al. (2012c)—(C–F),
Saunders et al. (2012)—(C–E); (H) courtesy of J.C. Edgar, adapted from Edgar
et al. (2013).
pharmacological (Saunders et al., 2012) and cellular manipula-
tion (Cardin et al., 2009; Sohal et al., 2009; Billingslea et al.,
2014), but it can provide insight into the human pathogenic
markers of ASD. Identifying an intermediate phenotype at the
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population activity level may allow the translational bridging
of basic, pre-clinical, and human-subject research. Furthermore
it provides additional bridging of the molecular to behavioral
domains.
Differences in circuit function activity in model systems may
be easier to interpret in terms of changes in clinical electro-
physiology found in EEG. There has been success modeling
social and behavioral deficits as markers of ASD-like symp-
tomatology (Silverman et al., 2010), yet questions remain of
how to fully model and validate the behavioral disturbances
seen in ASD and reliably link them with neurophysiological
differences. Recapitulating ensemble electrophysiological activ-
ity that is seen in patients with ASD can provide mecha-
nistic bridge between the construct validity of a model and
its behavioral phenotypes. Gandal et al. (2010) demonstrated
that the electrophysiological abnormalities seen in children
with ASD were recapitulated in a prenatal insult based mouse
model of ASD (Figure 1), and these changes correlated with
synaptic protein expression and behavior. Similarly analogous
changes have been seen in response to pharmacological treat-
ment (Saunders et al., 2012) and genetic manipulations (Gandal
et al., 2012a). Thus, with increasing evidence in animal mod-
els for recapitulation of EMEG phenotypes of ASD it becomes
important to ask what are the underlying neurophysiological
differences that mediate observed changes in cortical ensem-
ble activity that in turn lead to disrupted E/MEG activity in
ASD.
To make the link between circuit function and E/MEG dif-
ferences three areas of inquiry show promise: (1) direct cellular
modulation of local circuit properties; (2) assays of ensemble
activity linking circuit dysfunction to E/MEG phenotypes; and
(3) measures of functional connectivity. Below we discuss each
of these approaches.
CURRENT CIRCUIT LEVEL RESEARCH IN ASD: CURRENT
METHODOLOGIES FOR FUTURE ADVANCES
CELLULAR ASSESSMENT OF CIRCUIT ACTIVITY: TARGETING THE
NEUROPHYSIOLOGY OF LOCAL CIRCUIT DYSFUNCTION IN ASD
Recent basic science research at the microcircuit level has had
particular relevance to ASD. While there is a wealth of data
looking at synaptic or cellular firing properties in putative
models of autism, there are few studies that directly assay
modulation of circuit activity. An exception is in vitro work
in the hippocampus that looked at the role of the peptide
Oxytocin. Oxytocin, is a neuromodulatory peptide known to
be important in social bonding, prosocial behavior and social
recognition (Lieberwirth and Wang, 2014) and is reduced in
patients with ASD (Modahl et al., 1998), making it an area of
interest regarding therapeutics (Weisman et al., 2012; Gordon
et al., 2013; Tyzio et al., 2014). At the single cell level Oxy-
tocin was known to increase excitability (Raggenbass et al.,
1989). It was therefore surprising that in response to a com-
pound synaptic potential, where both local inhibitory and prin-
ciple cells are activated by synaptic input, oxytocin signaling
was shown to regulate the fidelity of stimulus produced fir-
ing and reducing baseline neural activity (Owen et al., 2013).
This was because the most prominent affect of oxytocin was to
increase spontaneous activity in the inhibitory neurons and thus
increase baseline GABA related inhibitory tone of the system.
By increasing spontaneous inhibitory activity, the feedforward
inhibitory signaling evoked by afferent stimuli was reduced. Thus
a more faithful transmission of signaling and better signal-to-
noise ratio was achieved (Owen et al., 2013; Figure 2). Such
increase in reliability may scale at the ensemble level to pro-
duce a greater trial-to-trial phase reliability detected in EEG
or MEG signal that is measured as increased ITC. Analysis at
this cellular circuit level in models relevant to ASD may sim-
ilarly identify underlying changes in reliability that could be
linked to reduced ITC in patients. Importantly, such a role
for oxytocin would be opaque, without studying the interac-
tions of excitatory and inhibitory cells within their microcircuit
context.
Studying microcircuits can also be used to study changes in
the number or strength of synaptic interconnections. Using a
model of prenatal exposure to the antiepileptic drug valproic
acid, which is associated with a ∼7 fold increased risk for
autism, Rinaldi et al. (2008) patch-clamped multiple connected
cells in cortical slices to measure connectivity between neurons.
Consistent with interpretations of hyper local connectivity from
post-mortem anatomical data, in valproic exposed animals they
showed local circuit hyper-connectivity and hyperactive cortical
local networks.
Mesoscopic level dysfunction can also be detected due to
immune system based insults. Alterations to the retinogeniculate
pathways, as well as more local cytoarchitectural alterations in
hippocampus, cortex and retina, are well documented in mice
with MHC class I proteins perturbations (Elmer and McAllister,
2012). Such architectural modifications are not the only effect
MHC class I related alterations, perturbations to in circuit func-
tion with regards to plasticity, and critical periods in several
animal models also exist (Boulanger, 2009). These changes in
plasticity can arise from changes to the intrinsic cellular properties
of neurons, such as increases in excitability and frequency of
mEPSCs (Boulanger, 2009). Following this trend, mice with MHC
related alterations can show altered E/I balance in cortex and
short term plasticity modifications in cerebellum (Elmer and
McAllister, 2012). Plasticity over the longer term is also aberrant
in these animal models were altered LTD/LTP is exhibited (Elmer
and McAllister, 2012).
Using monogenetic insults that mimic syndromes similar to
ASD, plasticity has also been found to be perturbed in multiple
animal models. In a mouse model of fragile X disorder, a dis-
order closely linked to ASD, mice demonstrated increased LTP
(Huber et al., 2002). Plasticity alterations have been found in
an model of Angelman syndrome, where again LTP and LTD
were perturbed (Yashiro et al., 2009). Moreover, these mice also
demonstrated altered visual cortex plasticity with decrease ocular
dominance following monocular derivation (Yashiro et al., 2009).
Alterations to visual cortex plasticity, was also demonstrated
in a mouse model of Rett’s syndrome, with a MeCP2 muta-
tion extending the period within which alterations could occur
(Tropea et al., 2009). Interestingly, when traditional measures
of spine phenotypes and protein production were recovered so
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FIGURE 2 | Effects of oxytocin at the circuit level. (A) Representative
response to Shaffer Collateral stimulation (vertical bar) of a CA1 pyramidal cell
(red—spike, TGOT—Thr4,Gly7-oxytocin—specific agonist for oxytocin
receptors) (B) Responses of presynaptic interneurons (gray—sweeps,
black—average) to TGOT, note effect is to increase baseline and reduce
stimulus evoked firing. (C) Time course of spike probability for both evoked
spikes (black) and spontaneous events (gray) from pyramidal neurons. Spike
probability in response to stimulation (D) and at baseline (E). Figure courtesy
of R.W. Tsien, adapted from Owen et al. (2013). *** P < 0.001, ** P < 0.01,
* P < 0.05, # P < 0.1.
was ocular dominance in a similar model of fragile X as used
by Huber et al. (2002) and Dölen et al. (2007). Such ocular
dominance can be measured as an ensemble activity by ana-
lyzing visual event related potentials. This demonstrates both
monogenetic models and immune system dysfunction can pro-
duce measured circuit level dysfunction, and therefore may have
promise in identifying common features of circuit related disorder
in ASD.
ENSEMBLE ACTIVITY
Ultimately, to produce changes measured at an EEG electrode,
micro-circuit changes need to be expressed by large numbers
of neurons producing ensemble activity. Using voltage sensi-
tive dye imaging (VSDi), that can measure voltage changes
across all the excitable membrane (Box 2), this ensemble activ-
ity can be studied directly in slices. Comparable changes as
predicted by cellular studies, have been found in other models
of ASD and ASD-related syndromes. For instance mice lack-
ing MeCP2, which model Rett Syndrome, have been shown
to be hyperexcitable, and possibly hyperconnected, within hip-
pocampal circuits using VSDi, shedding light on previous
dichotomous results of single cell recordings (Calfa et al.,
2011).
While it appears that circuit-level study of animal models that
recapitulate key aspects of ASD are finding common alterations,
there has yet to be one study or set of studies that takes one model
of ASD and examines it from the cellular through to the EEG
level, thus directly linking the cellular to the ensemble and on to
intermediate phenotypes and behavior.
While experiments in vitro using animal models that recre-
ate key aspects of ASD have demonstrated promise, work
targeting ensemble activity that generate abnormal oscillatory
activity in ASD could provide vital cues. By extrapolating the
interaction of known cellular components and their connec-
tivity, and modeling them as circuits in silico, pioneers in
the field of neuronal oscillations made great strides in iden-
tifying the types of circuit activity that can generate specific
patterns of oscillations recorded by EEG. Original in vitro
work combined field, intracellular recordings and modeling
to identify the neurophysiological elements that support such
ensemble activity (Traub et al., 1996, 1999; Ermentrout and
Kopell, 1998). These groups identified intracellular and specific
cellular qualities that could generate gamma-band activity,
which included potassium channel subtypes, spike conductance
trajectories and a strong role for both glutamatergic and
GABAergic signaling (Buzsáki and Wang, 2012). One repeated
finding was that gamma-band activity occurring around 40
Hz band is strongly dependent on GABA receptor activity
(Whittington et al., 2000). Thus, in diseases much of the
focus on gamma-band abnormalities has been the role of
inhibition.
Studying gamma band activity at the local ensemble level
takes advantage of the fact that gamma-band (30–100 Hz)
activity measured by E/MEG are produced by synchronous
neuronal activity arising from these local cortical interactions
(Buzsáki and Wang, 2012; Buzsáki et al., 2012). By assaying
and modulating ensemble activity, researchers have been able
to identify the cell types involved and begin to validate their
impact on EEG using modern measures and modulation of
ensemble activity. As such the E/MEG detected phenotypes
of ASD can be teased apart, potentially leady to a common
substrate.
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BOX 2 | In vitro techniques to study spatial and temporal
qualities of cortical gamma-band abnormalities.
Voltage sensitive dye imaging allows for the direct assay of
membrane voltage. Because of most of the excitable membrane
available for VSDI in the brain is found in dendrites (for review see
Chemla and Chavane, 2010) the VSDI signals are biased towards
the membrane that is most involved in generating the cortical
cellular dipoles recorded at the MEG or EEG sensors (Buzsáki
et al., 2012). When used to study the population level, the summed
membrane responses can measure the kinetics of the membrane
response and this can be associated with differences in EEG
responses at the in vivo level (Carlson et al., 2011) as well as
being amenable to direct examination via time frequency analysis
(Figure 3).
Similar to how sensory-elicited changes in cortical population
responses are reflected in E/MEG power (Figure 1), in vitro stud-
ies can use the population responses driven by electrically evoked
afferent activity to more directly study the interplay between
excitatory input and the coupled oscillations of excitatory and
inhibitory neurons. In areas such as the neocortex and area CA3,
which support spontaneous population gamma events in vitro
(Köhling et al., 2000; Csicsvari et al., 2003; Cunningham et al.,
2004), afferent stimulation will generate an increase in membrane
potential as well as power when frequency is analyzed (Figure 3;
Prechtl et al., 1997). Thus, these more complex local interac-
tions can reveal the same time-frequency components measured
from repeated sensory stimulation in human subjects, including
evoked, ITC and induced power, as well as the spectral background
population activity. In EEG/MEG these different components can
be mapped to specific dipoles. When these components are
identified in vitro using VSDi, they also can similarly be mapped
back to specific lamina and the extent of functional coupling
among horizontal components measured (Figure 3). This level
of laminar specificity may be important for identifying the cortical
circuit components that are disrupted in ASD. In auditory cortex it
has been demonstrated that higher frequency gamma oscillations
(50–80 Hz) occur primarily in layer 4, with a high dependence on
NMDA signaling (Ainsworth et al., 2011). On the other hand lower
frequencies of gamma oscillations (30–45 Hz) arose from layer 2
and 3 are highly reliant on gap junctions (Ainsworth et al., 2011).
Using cortical slice preparations from validated models of EEG
phenotypes, it appears possible to map E/MEG endophenotypes
of ASD to specific lamina (Figure 3E). As these laminae are
characterized by specific developmental origin, cell types and
connectivity, identifying the laminae involved in producing specific
EEG phenotypes can help detect the developmental and cellular
etiology underlying the E/MEG phenotypes.
TARGETING SPECIFIC CELLULAR COMPONENTS TO UNDERSTAND
THEIR IMPACT ON ENSEMBLE ACTIVITY
Post-mortem studies and transgenic models where genetic
changes are limited to specific cell types anatomical areas have
suggested that changes primarily limited specific cell types and
brain areas may underlie ASD related symptoms and clinical elec-
trophysiological abnormalities. Using optogenetics to optically
excite or inhibit specific cell types involved in oscillatory activity
has shown great promise to directly test these hypotheses. The
prominent role of parvalbumin (PV) fast spiking cells in generat-
ing high-frequency oscillations was demonstrated by specifically
expressing the photoactivated Cl− pump halorhodopsin in vivo
(Sohal et al., 2009). The reduction in gamma-band activity when
PV cells were disabled is consistent with the role of GABA
receptors in high-frequency activity. This study was in line with
evidence of the role of PV cells in disorders such as schizophrenia,
which demonstrate both disruptions in PV cell immunoreactivity
(Zhang and Reynolds, 2002) and gamma-band function (Sun
et al., 2011). Optogenetics has also been used to link in vivo
cortical E/I balance, gamma-band oscillations and social behavior
by directly increasing excitation in the medial prefrontal cortex
(Yizhar et al., 2011). Though there are limited indications that PV
cells are disrupted in autism (Lawrence et al., 2010) connectivity
involving these and other inhibitory cells types may be abnormal,
which may lead to multiple changes in cell type excitability
(Zikopoulos and Barbas, 2013). The problem therefore remains
that within ASD, differing cell types, synaptic disruptions or
connectivity may contribute to similar oscillatory dysfunction.
Because optogenetics can be used to excite and inhibit different
genetically targeted cell types or anatomical areas, it is well suited
to probe the differential contributions of cellular and synaptic
dysfunction that may lead to changes in oscillatory activity. In
particular where the specific disruption in the E/I balance or
connectivity may lead to increased excitation in one cell type
and reduced excitation in another, the use of ontogenetic probes
with different excitation wavelengths and kinetics can potentially
mimic or more fully reverse those conditions (Yizhar et al.,
2011).
ASSESSING FUNCTIONAL CONNECTIVITY WITHIN THE CORTEX
Circuit based findings could also aid in testing other hypotheses
of ASD. Connectivity, and in particular regulation of functional
connectivity is very apt to be studied using circuit/ensemble based
techniques as demonstrated in Wilson et al. (2012). Moreover
Gray et al. (1989) demonstrated the ability to examine ensemble
functional connectivity within cortex, akin to what is detected
with EEG but with more precision. Here recording sites located
in non-overlapping receptive fields of visual cortex with similar
preferred orientation, synchronized maximally for a stimuli that
were continuous between recording site’s respective receptive
fields. Ensemble functional connectivity remains of consequence
because along with changes in cellular and receptor properties,
alterations in cortical connectivity have been reported in subjects
with ASD (Belmonte et al., 2004). High-density electrode arrays
or VSDI recordings in vitro from cortical slices and in vivo from
cortical surface can be used to assay the functional connectivity
that is associated with local coherence in E/MEG. An immediate
area of investigation could directly identify how connectivity is
mediated (e.g., directly via axon connectivity or via unmasking
of surround inhibition), using in vitro pharmacological tools and
differing ionic composition (Ang et al., 2005). Ultimately it could
provide functional analysis of layer specific connectivity; while
directly imaging the surface in vivo can precisely map the extent
of activity in animals modeling ASD.
Changes in functional connectivity can be incredibly sensitive
to alterations to even molecular constituents. For example knock-
ing out the potassium channel KV3.2 in mice reduces high fre-
quency, but not low frequency correlated activity within cortical
locations. In these KV3.2 −/− mice, the lack of high frequency
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FIGURE 3 | Voltage sensitive dye imaging signals are amenable to
time-frequency decomposition. (A) Auditory cortex VSDi responses to
single stimulation (left) and burst stimulation at 40 Hz of white matter
input tracts (right). Top—2D representation of evoked response [green
square—ROIs used below]. Middle—VSDi florescence traces of the ROI
depicted in above for single stimulation (left) and burst stimulation (right).
Bottom—30–50 Hz ITC calculated for same ROI. (B) Time frequency plots
for single stimulation (left) and burst stimulation (right). Note that the
single stimulation time frequency plot can be separated not only into high
and low gamma, but also stimulus related (black boxes) and baseline
activity (gray boxes). For the burst stimulated time frequency plot a large
increase in power occurs around the frequency that is stimulated at (black
box). (C) Parsed stimulus related activity (i) and baseline activity (ii) for
the single stimulation paradigm demonstrated in (B) [left—time frequency
plot, right—image profile of time frequency plot]. Note local peak of
activity at 40 Hz in image line profile for both stimulus related activity and
baseline. (D) Parsed period of stimulation [left—time frequency plot,
right—image profile of time frequency plot] for the 40 Hz burst stimulation
paradigm demonstrated in (B). Note large increase in 40 Hz power. (E)
Series of stills from a region of interest (green dashed box in gray scale
image shows relative location) in response to a single stimulation (left)
and a 40 Hz burst stimulation (right) [top frames—standard VSDi imaging
measure; bottom frames—35–55 Hz band passed movie from which
pixel-wise ITC has been calculated and overlaid back onto grayscale
image]. Note that this analysis allows the determination of laminar and
regional existence of inter-trial coherence (ITC).
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coherence was not due to single site reductions in high frequency
power, which were unchanged from wild type counterparts, but
alterations in coherence (Harvey et al., 2012). Such changes to
coherence have the potential to cause behavior abnormalities in
in vivo systems. Operant learning has been shown to be coincident
with increase in coherence between striatum and amygdala via
coupling in the high frequency range (Popescu et al., 2009).
While anxiety has been associated with increase in hippocampal
synchrony between the hippocampus and prefrontal cortex at
theta frequency (Adhikari et al., 2011). Such specificity of high-
frequency coherence may be opaque to imaging modalities with
lower temporal resolution, such as fMRI, or less spatial resolution
for deep structures, such as E/MEG. Thus, preclinical models may
be the only efficient way to studying disease specific disruption
of such functional connectivity between coupled nuclei at higher
frequencies.
PRE-CLINICAL EEG AND LFP RECORDINGS
In vivo population recording in mice and rats obtained using
implanted electrodes to measure EEG also provide useful circuit
based insights into ASD. The ability to detect analogous alter-
ations in population activity as seen in ASD was demonstrated
with the prenatal VPA insult model of ASD as well through
genetic reduction in NMDA receptors (Figure 1; Gandal et al.,
2010, 2012a). The behavioral deficits seen in this NR1 reduction
model correlate with the observed increase in gamma-band power
(Gandal et al., 2012c). More importantly, in this model reduction
of ASD-like symptomatology was mirrored by a rectification of
gamma-band activity (Gandal et al., 2012c). Such changes in
baseline power prompted the examination of clinical data, where
similar increases in power was found in children with ASD (Edgar
et al., 2013), demonstrating directly the important of translational
electrophysiology. Similar techniques are now being combined
with cell-selective receptor manipulations, producing differing
phenotypes, both for behavior and ensemble activity recordings
(Billingslea et al., 2014). Such an approach may be useful in other
models where cell or location specific genetic modifications have
led to ASD related phenotypes.
CURRENT LIMITATIONS OF THIS APPROACH
Focusing on circuit level analysis of ASD pathogenic mechanisms
does have its own weaknesses. For example findings of delays
and reduced dynamic range in electrophysiological markers of
auditory processing (M100) in ASD have been well documented
(Roberts et al., 2008; Figure 1). Currently such phenomena are
difficult for circuit level analysis to dissect as it likely involves
complex system level interactions that are difficult to assay. Never-
theless, recent improvements in technique such as multielectrode
recordings in rodent cortex has allowed investigators to tease
out different onset latencies in auditory fields and coherence
between auditory fields (Centanni et al., 2013). Such work is
showing promise at illuminating the regional electrophysiolog-
ical dysfunctions within the auditory fields associated with an
environmental insult thought to model ASD in rodents (Engineer
et al., 2014).
Another important challenge for the circuit level approach is
to determine the exact role that the observed electrophysiological
abnormalities play in the specific symptomatology of ASD,
whether they are specific to core symptoms or more cognitive
issues. This is of importance because of the appearance of similar
electrophysiological findings in disorders such as schizophrenia
(Uhlhaas and Singer, 2006; Gandal et al., 2012b). In schizophre-
nia, gamma-band alterations are correlated to negative symp-
tomatology and treatment resistant symptoms, and have to be
shown to mirror improved cognitive activity after pharmacolog-
ical treatments (Gandal et al., 2012b). The exact relation of local
circuit activity to behavioral outcomes across multiple disorders
must be established.
The question of specificity of electrophysiological findings
with regards to ASD symptomatology also arises since the afore-
mentioned markers, such as disrupted gamma-band activity,
have been found in first degree relative of patients with ASD
(Rojas et al., 2008, 2011; McFadden et al., 2012). First-degree
relatives of patients with ASD often exhibit a broad autism
phenotype however (Losh et al., 2008), and as such may reflect
this behavioral predisposition. This leads to hypothesis that
electrophysiological makers such as M100 delay and gamma-
band dysfunction may signal a risk for ASD or schizophrenia
rather than be a sign of the disease, thus more clinical work is
needed to better understand the role of high-frequency changes
in activity associated with ASD. Nevertheless, this does not
limit the importance of understanding the circuit mechanisms
underlying these common E/MEG phenomena, rather it sug-
gest care in interpretation and a need to dissect the connection
between disordered circuit activity and behavior. Conversely,
recovery of normal gamma-function appears to predict amelio-
ration of behavioral deficits in some models of ASD (Gandal
et al., 2012c), and inducing higher baseline gamma-band activ-
ity can inhibit social exploration (Yizhar et al., 2011). Such
studies have not been completed in ASD patients. If such a
link between E/MEG and treatment efficacy is established in
patients, the significance of such circuit level studies will increase
significantly.
SUMMARY: CIRCUIT-LEVEL EXAMINATION SHOWS
POTENTIAL FOR UNIFYING THE CURRENT STATE OF ASD
FINDINGS
Synaptic dysfunction, local and long range alterations in con-
nectivity, as well as aberrant modulation can each contribute to
altered circuit function, leading to abnormal ensemble activity
and disordered brain function. Such changes in brain function
likely result in the symptoms of ASD. These changes in ensem-
ble activity and brain function are reflected in differences in
EEG, MEG and other functional imaging modalities, yet the
actual neurophysiologic mechanisms remain to be identified.
The current and developing techniques available to investigators
finally allows for the examination of circuit related alterations
in ASD, which is critical to bridging cellular and molecular
changes commonly studied in animal models and recent clinical
electrophysiology from patients with ASD. Circuits that produce
gamma-oscillations appear sensitive to changes ranging from
subcellular expression to white matter tract alterations. These
circuit abnormalities also appear to be a locus where different
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ASD-related markers produce similar effects, thus the ASD related
gamma changes are a fruitful area for translational inquiry. For
instance gamma-band activity has been correlated to hallmark
behavioral phenotypes (Rojas et al., 2011), and translational
research has demonstrated behavioral improvement due to phar-
macological treatment can mirror amelioration of gamma-band
function in preclinical models (Gandal et al., 2012c), indicating
such an approach can help lead to better treatments in human
patients.
Other psychiatric disorders (ADHD and schizophrenia) have
similar genetic underpinnings with ASD (Cross-Disorder Group
of the Psychiatric Genomics Consortium; Genetic Risk Outcome
of Psychosis (GROUP) Consortium, 2013). There is also similar
changes in resting and evoked gamma, and a differential impact
on EEG coherence between and within hemispheres in these
disorders (Uhlhaas and Singer, 2006). Thus, the study of circuit
dysfunction in ASD may refine the unique or common cellular
character of the E/I imbalance and connectivity seen in mul-
tiple disorders. In particular further developing these measures
in models and patients can provide the basis for testing the
interaction of specific circuit abnormalities and cognitive and
behavioral domains associated with these diseases as codified in
the Research Domain Criteria by the NIMH (RDoC). As such
these developing measures may provide the necessary neurophys-
iological foundation for understanding differences within ASD
and between ASD and other psychiatric disorders. By identifying
these mechanisms we can design interventions that directly target
circuit function.
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